These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
664 related items for PubMed ID: 20350693
21. Ultrafiltration for the treatment of diuretic-resistant, recurrent, acute decompensated heart failure: experience in a single center. De Maria E, Pignatti F, Patrizi G, Benenati PM, Ricci S, Cappelli S. J Cardiovasc Med (Hagerstown); 2010 Aug; 11(8):599-604. PubMed ID: 20442667 [Abstract] [Full Text] [Related]
22. Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF. Grodin JL, Carter S, Bart BA, Goldsmith SR, Drazner MH, Tang WHW. Eur J Heart Fail; 2018 Jul; 20(7):1148-1156. PubMed ID: 29493059 [Abstract] [Full Text] [Related]
23. Decongestive treatment of acute decompensated heart failure: cardiorenal implications of ultrafiltration and diuretics. Freda BJ, Slawsky M, Mallidi J, Braden GL. Am J Kidney Dis; 2011 Dec; 58(6):1005-17. PubMed ID: 22014726 [Abstract] [Full Text] [Related]
32. Ultrafiltration in the management of acute decompensated heart failure. Mielniczuk LM, Haddad H, Davies RA. Curr Opin Cardiol; 2010 Mar; 25(2):155-60. PubMed ID: 19996964 [Abstract] [Full Text] [Related]
33. The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance. Givertz MM, Massie BM, Fields TK, Pearson LL, Dittrich HC, CKI-201 and CKI-202 Investigators. J Am Coll Cardiol; 2007 Oct 16; 50(16):1551-60. PubMed ID: 17936154 [Abstract] [Full Text] [Related]
35. Patients with high-dose diuretics should get ultrafiltration in the management of decompensated heart failure: a meta-analysis. Shi X, Bao J, Zhang H, Wang H, Li L, Zhang Y. Heart Fail Rev; 2019 Nov 16; 24(6):927-940. PubMed ID: 31209772 [Abstract] [Full Text] [Related]
38. Fluid restriction in the management of decompensated heart failure: no impact on time to clinical stability. Travers B, O'Loughlin C, Murphy NF, Ryder M, Conlon C, Ledwidge M, McDonald K. J Card Fail; 2007 Mar 16; 13(2):128-32. PubMed ID: 17395053 [Abstract] [Full Text] [Related]
39. Continuous ultrafiltration for congestive heart failure: the CUORE trial. Marenzi G, Muratori M, Cosentino ER, Rinaldi ER, Donghi V, Milazzo V, Ferramosca E, Borghi C, Santoro A, Agostoni P. J Card Fail; 2014 May 16; 20(5):378.e1-9. PubMed ID: 25089313 [Abstract] [Full Text] [Related]
40. N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study. Berger R, Moertl D, Peter S, Ahmadi R, Huelsmann M, Yamuti S, Wagner B, Pacher R. J Am Coll Cardiol; 2010 Feb 16; 55(7):645-53. PubMed ID: 20170790 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]